Circulating monocytes serve as novel prognostic biomarker in pancreatic ductal adenocarcinoma patients

HIGHLIGHTS

• who: Frederik J. Hansen and collaborators from the Department of General and Visceral Surgery, Friedrich-Alexander-University, Krankenhausstrau00dfe, Erlangen, Germany have published the article: Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients, in the Journal: Cancers 2023, 15, 363. of /2023/
• what: Based on the findings the authors propose monocytes as a novel prognostic biomarker. The authors aimed to delineate the role of monocytes in PDAC.
• how: Survival data were analyzed using the Log-rank (Mantel-Cox) test.
• future: More studies are needed to establish actual use . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.